McKesson Corporation

MCK

$156.41

+5.59% (1 year change)

Avg closing price

Price range

Market Cap

$25.4 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$55.7 Billion

Total revenue in the last quarter.

Net Income

$444 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$5.69

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$1.64 (1.05%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

27.48x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$646 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

80,000

The number of full time employees.

Revenue & Earnings

Balance Sheet

McKesson Corporation

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

News

McKesson Co. (NYSE:MCK) Expected to Post Quarterly Sales of $59.33 Billion

McKesson Co. (NYSE:MCK) Expected to Post Quarterly Sales of $59.33 Billion

Analysts predict that McKesson Co. (NYSE:MCK) will announce $59.33 billion in sales for the current quarter, Zacks reports. Five analysts have provided estimates for McKesson’s earnings. The highes...

Daily Political Daily Political, 4 days ago
Healthcare Quality Management Market Study and Professional In-Depth Analysis 2020-2027 | Cerner, Mckesson, Nuance Communications, Premier, Verscend Technologies, Quantros

Healthcare Quality Management Market Study and Professional In-Depth Analysis 2020-2027 | Cerner, Mckesson, Nuance Communications, Premier, Verscend Technologies, Quantros

The research report on the Healthcare Quality Management Market provides professional in-depth analysis available on the market status and latest trends, including growth, opportunities, competitiv...

OpenPR OpenPR, 8 days ago
Impact of COVID-19 on Online Healthcare Technology Market to Witness Steady Growth Based on Rising Significance in Healthcare Sector Till 2027 by Key Players McKesson Corporation, United Healthcare Group, Allscripts Healthcare Solutions, Athenahealth

Impact of COVID-19 on Online Healthcare Technology Market to Witness Steady Growth Based on Rising Significance in Healthcare Sector Till 2027 by Key Players McKesson Corporation, United Healthcare Group, Allscripts Healthcare Solutions, Athenahealth

Healthcare technology is defined by the World Health Organization as the "application of organized knowledge and skills in the form of devices, procedures, and systems developed to solve a health p...

OpenPR OpenPR, 10 days ago